福瑞股份股价跌5.01%，睿远基金旗下1只基金位居十大流通股东，持有492.73万股浮亏损失1837.87万元

Group 1 - The core point of the news is that Furuya Co., Ltd. experienced a 5.01% drop in stock price, closing at 70.75 yuan per share, with a trading volume of 5.25 billion yuan and a turnover rate of 3.13%, resulting in a total market capitalization of 187.47 billion yuan [1] - Furuya Co., Ltd. is primarily engaged in the production and sales of drugs in the liver disease sector, as well as the research and sales of medical instruments and medical services. The revenue composition is as follows: 67.57% from equipment and technology, 27.47% from pharmaceuticals, 4.30% from medical services, and 0.65% from other sources [1] Group 2 - Among the top ten circulating shareholders of Furuya Co., Ltd., a fund under Ruiyuan Fund holds a significant position. Ruiyuan Growth Value Mixed A (007119) reduced its holdings by 639,300 shares in the third quarter, now holding 4.9273 million shares, which accounts for 2.11% of the circulating shares. The estimated floating loss today is approximately 18.3787 million yuan [2] - Ruiyuan Growth Value Mixed A (007119) was established on March 26, 2019, with a current scale of 21.387 billion yuan. Year-to-date returns are 68.09%, ranking 478 out of 8,152 in its category; the one-year return is 64.4%, ranking 546 out of 8,038; and since inception, the return is 100.9% [2]